Mark Dampier: Biotechnology could boost income fund


When Bill Mott launched the PSigma Income fund in 2007 I suggested it was a good choice for income and growth investors. Unfortunately performance has not lived up to expectations. It hasn't helped that the fund was launched at the peak of the stock market in 2007. Some initial holdings in the banks also didn't help, although to be fair to Mr Mott he soon changed this.

He has been wary and far from convinced we have fully recovered from the excesses of the early and mid-2000s, and preferred to invest in larger, more defensive companies which tend to be less reliant on strong economic growth for success. With hindsight it is plain to see small and medium-sized high yield companies were the best areas in which to invest.

Many investors question my continued faith in Mr Mott, but I believe PSigma's merger with Miton Investment Managers last year will be positive for the fund; I'm not ready to write it off yet. Gervais Williams, a highly successful small and medium-sized company fund manager, will support Mr Mott on a day-to-day basis. While not directly involved with this fund, the emerging talent of George Godber also adds strength to the wider team. This new structure should bring forward better stock ideas to complement Mr Mott's underlying, and usually correct, economic views.

The influence of Mr Williams is already being felt. He added Quindell; a consulting, software and outsourcing specialist, to the portfolio and initial results are encouraging. It is one of Mr Williams's top stocks from his other funds and while it is currently quoted on AIM it is expected to step up to the FTSE 250 index in due course.

The fund is not going to become small and mid-cap oriented. It is expected to have 10 to 15 per cent exposure to this area. Elsewhere, Mr Mott continues to focus on the pharmaceutical and biotechnology theme, where around 20 per cent of the fund is invested. He remains convinced these sectors will "embark on a multi-year opportunity". Key holdings are GlaxoSmithKline and AstraZeneca in the UK; and Novartis, Roche and Bristol-Myers Squibb overseas.

Overall, the team asks itself five simple questions: what are the prospects for a rise in turnover? Can corporate margins be sustained? Is the management team good enough? How much financial headroom is there in the balance sheet? Are there low expectations in the share price?

This system helps give the team an objective view on each company. Examples include SSE, which has a balance sheet that looks worse than first appears; and food retailers such as Tesco and Sainsbury's which are losing market share. These positions have now been sold.

New additions to the fund have included Royal Mail and Stobart Group.

I think its bias to larger companies might begin to pay off over the next few years, as this area is beginning to look good value relative to smaller and medium-sized companies which have had such a good run recently.

Mark Dampier is head of research at Hargreaves Lansdown, the asset manager, financial adviser and stockbroker. For more details about the funds included in this column, visit

Independent Partners; Do you need financial advice on your investments, pension or insurance? Book a free consultation with an independent Financial Adviser at

Finacial products from our partners
Property search
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    Recruitment Genius: Payments Operations Assistant

    £23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

    Recruitment Genius: Telephone Debt Negotiator

    £13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

    Guru Careers: Communications Exec / PR Exec

    £25 - £30K: Guru Careers: We are seeking a highly-motivated and ambitious Comm...

    Guru Careers: Pricing Analyst

    £30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...

    Day In a Page

    On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

    On your feet!

    Spending half the day standing 'reduces risk of heart attacks and cancer'
    Liverpool close in on Milner signing

    Liverpool close in on Milner signing

    Reds baulk at Christian Benteke £32.5m release clause
    With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

    The big NHS question

    Why are there so few new GPs when so many want to study medicine?
    Big knickers are back: Thongs ain't what they used to be

    Thongs ain't what they used to be

    Big knickers are back
    Thurston Moore interview

    Thurston Moore interview

    On living in London, Sonic Youth and musical memoirs
    In full bloom

    In full bloom

    Floral print womenswear
    From leading man to Elephant Man, Bradley Cooper is terrific

    From leading man to Elephant Man

    Bradley Cooper is terrific
    In this the person to restore our trust in the banks?

    In this the person to restore our trust in the banks?

    Dame Colette Bowe - interview
    When do the creative juices dry up?

    When do the creative juices dry up?

    David Lodge thinks he knows
    The 'Cher moment' happening across fashion just now

    Fashion's Cher moment

    Ageing beauty will always be more classy than all that booty
    Thousands of teenage girls enduring debilitating illnesses after routine school cancer vaccination

    Health fears over school cancer jab

    Shock new Freedom of Information figures show how thousands of girls have suffered serious symptoms after routine HPV injection
    Fifa President Sepp Blatter warns his opponents: 'I forgive everyone, but I don't forget'

    'I forgive everyone, but I don't forget'

    Fifa president Sepp Blatter issues defiant warning to opponents
    Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report

    Weather warning

    Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report
    LSD: Speaking to volunteer users of the drug as trials get underway to see if it cures depression and addiction

    High hopes for LSD

    Meet the volunteer users helping to see if it cures depression and addiction
    German soldier who died fighting for UK in Battle of Waterloo should be removed from museum display and given dignified funeral, say historians

    Saving Private Brandt

    A Belgian museum's display of the skeleton of a soldier killed at Waterloo prompts calls for him to be given a dignified funeral